Confined or spread disease-Confined to the prostate gland - Page 4 of 13 Posts on Medivizor
Navigation Menu

Confined or spread disease-Confined to the prostate gland Posts on Medivizor

Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after brachytherapy

Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after brachytherapy

Posted by on Jun 30, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of salvage high-intensity focused ultrasound (S-HIFU) in patients with locally recurrent prostate cancer (LRPC; cancer which has come back and is confined to the prostate gland) after treatment with low dose rate brachytherapy (BT).  The authors concluded that S-HIFU is...

Read More

Searching for patients with prostate cancer to test low-dose or high-dose brachytherapy

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness and safety of low dose rate (LDR) vs high dose rate (HDR) prostate brachytherapy (BT) for patients with prostate cancer (PC). The main outcome to be measured will be the quality of life in terms of urinary symptoms. This trial is recruiting in British Columbia,...

Read More

Evaluating the impact of radiotherapy vs. active surveillance on quality of life in men with localized prostate cancer

Evaluating the impact of radiotherapy vs. active surveillance on quality of life in men with localized prostate cancer

Posted by on Mar 29, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined the impact of different prostate cancer treatments on quality of life. This study concluded stereotactic body radiotherapy (SBRT) and active surveillance resulted in a similar quality of life in the long term. Some background Radiation therapy (RT) is a common treatment for localized (confined) prostate cancer....

Read More

Looking at different types of radiation therapy for intermediate risk prostate cancer

Looking at different types of radiation therapy for intermediate risk prostate cancer

Posted by on Feb 23, 2019 in Prostate cancer | 0 comments

In a nutshell This trial evaluates the effectiveness of radiation therapy delivered from outside the body for the treatment of prostate cancer. The main outcomes of this trial are the number of patients who have no damage to genital or urinary organs and survival without cancer. This trial is taking place in various sites across the USA and...

Read More

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Posted by on Nov 28, 2018 in Prostate cancer | 0 comments

In a nutshell This study investigated the effect of apalutamide (Erleada) on health-related quality of life (H-QoL) in patients with prostate cancer. This study found that apalutimide preserved H-QoL while prolonging time taken for cancer to spread.  Some background One treatment option for patients with prostate cancer is androgen...

Read More

Evaluating optimal duration of androgen deprivation therapy in high risk prostate cancer

Evaluating optimal duration of androgen deprivation therapy in high risk prostate cancer

Posted by on Nov 25, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the effect of the length of androgen deprivation therapy (ADT) when used with radiotherapy in patients with prostate cancer. This study found that 18 months ADT led to similar overall survival and better quality of life as compared to 36 months in these patients.  Some background...

Read More

Better survival for patients with new metastatic prostate cancer with previous prostate surgery

Better survival for patients with new metastatic prostate cancer with previous prostate surgery

Posted by on Oct 19, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the effect previous treatment has on overall survival for patients with metastatic (spread) prostate cancer. This study found that patients who had previous prostate surgery and radiation had improved overall survival.  Some background Localized prostate cancer can be treated using prostate-removing...

Read More

2018 recommendations for the treatment of localized prostate cancer: Part II

2018 recommendations for the treatment of localized prostate cancer: Part II

Posted by on Sep 25, 2018 in Prostate cancer | 0 comments

In a nutshell This article reviewed treatment guidelines that have been recommended for patients with early-stage prostate cancer. Some background This analysis of existing treatment guidelines was done by the leading experts in prostate cancer research. They have made recommendations on the treatment of early-stage prostate cancer.  Methods...

Read More

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Posted by on Sep 7, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate if MRI scans (a test that takes detailed images of inside the body) could safely replace biopsies (samples taken from tissues for close examination) in active surveillance for prostate cancer. This study found that men with low-risk disease can be monitored using MRI and PSA levels with selective...

Read More